Biotechnology BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB) May 20, 2022
Biotechnology AXSM SHAREHOLDER ALERT: Jakubowitz Law Reminds Axsome Shareholders of a Lead Plaintiff Deadline of July 12, 2022 May 20, 2022
Press Release Lawsuits Filed Against Vrt, Abbv And Ibm – Jakubowitz Law Pursues Shareholders Claims May 19, 2022
Biotechnology AXSM LAWSUIT ALERT: Levi & Korsinsky Notifies Axsome Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline May 19, 2022
Biotechnology E3 Metals: Unlocking a New Source of Canadian Lithium for a Sustainable Energy Future May 19, 2022
Search
Health
